Comparison of the Fluoroquinolones Based on Pharmacokinetic and Pharmacodynamic Parameters
Authors:
- 1 April 2000
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 20 (4) , 417-428
Abstract
Assessment of pharmacodynamic activity from standard in vitro minimum inhibitory concentrations (MICs) alone is insufficient to predict in vivo potency. Achievable serum and tissue concentrations as well as pharmacokinetic characteristics must be considered. When pharmacokinetic and pharmacodynamic values are combined, the area under the inhibitory curve (AUIC) and peak concentration: MIC ratio predict clinical cure for fluoroquinolones. Clinical data and animal models indicate that a peak:MIC of 10:1 and above and an AUIC of 125 and above are predictive of a clinical cure for this class of antimicrobials against gram‐negative organisms. The values may be used to compare and contrast fluoroquinolones to determine which would be best for treating a specific microorganism. Pharmacodynamic data also can be used to design regimens that minimize the risk of suboptimal drug levels. Ensuring the optimal fluoroquinolone dosage based on pharmacodynamic principles would diminish the emergence of resistant organisms and prevent treatment failures.Keywords
This publication has 77 references indexed in Scilit:
- Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumoniaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- TrovafloxacinDrugs, 1997
- GrepafloxacinDrugs, 1997
- SparfloxacinDrugs, 1997
- The Clinical Pharmacokinetics of LevofloxacinClinical Pharmacokinetics, 1997
- Effect of Age and Gender on the Pharmacokinetics of GrepafloxacinClinical Pharmacokinetics, 1997
- Pharmacokinetics of Grepafloxacin after Oral Administration of Single and Repeat Doses in Healthy Young MalesClinical Pharmacokinetics, 1997
- EFFECT OF NEW QUINOLONE, CP-99,219–27, IN CURING INTRAABDOMINAL ABSCESSES IN RATSInfectious Diseases in Clinical Practice, 1996
- Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteersJournal of Antimicrobial Chemotherapy, 1996
- Kinetics of antimicrobial activityThe Journal of Pediatrics, 1986